CareTrust REIT
CTRE Β· Health Care REITs
$36.62
0.0%Healthcare Realty Trust
HR Β· Health Care REITs
$17.95
0.1%The short version
- Healthcare Realty Trust is the larger business, with $1.2B of revenue in fiscal 2025 against $476M for CareTrust REIT, about 2.5 times as much.
- CareTrust REIT grew revenue faster (60.8%, against β6.9%).
| Latest fiscal year | CTRE Β· FY25 | HR Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $8.6B | $6.1B |
| Revenue | $476M | $1.2B |
| Free cash flow | β | $127M |
| Net income | $321M | β$246M |
| Growth | ||
| Revenue growth | 60.8% | β6.9% |
| 5-year growth | 21.7% | 18.8% |
| Share count change | 31.5% | β4.3% |
| Profitability | ||
| Gross margin | β | β |
| Operating margin | β | β |
| Net margin | 67.3% | β20.8% |
| FCF margin | β | 10.8% |
| Return on capital | 9.3% | β |
| Return on equity | 9.2% | β5.0% |
| Balance sheet | ||
| Net debt | $696M | $4.0B |
| Net debt / EBITDA | 1.5x | β |
| Dividends and buybacks | $259M | $391M |
| Valuation & quality | ||
| P/E | 22.9x | β |
| Piotroski F-score | β | β |
FY16
CTRE $105M
HR $461M
FY17
CTRE $133M
HR $614M
FY18
CTRE $157M
HR $696M
FY19
CTRE $163M
HR $692M
FY20
CTRE $178M
HR $500M
FY21
CTRE $192M
HR $535M
FY22
CTRE $196M
HR $933M
FY23
CTRE $218M
HR $1.3B
FY24
CTRE $296M
HR $1.3B
FY25
CTRE $476M
HR $1.2B
CTRE
HR
FY16
CTRE β
HR 22.1%
FY17
CTRE β
HR 20.1%
FY18
CTRE β
HR β
FY19
CTRE β
HR β
FY20
CTRE β
HR β
FY21
CTRE β
HR β
FY22
CTRE β
HR β
FY23
CTRE β
HR β
FY24
CTRE β
HR β
FY25
CTRE β
HR β
CTRE
HR
FY16
CTRE $64.3M
HR $161M
FY17
CTRE $88.4M
HR $243M
FY18
CTRE $97.6M
HR $260M
FY19
CTRE $123M
HR $249M
FY20
CTRE β
HR $395M
FY21
CTRE β
HR $135M
FY22
CTRE β
HR $109M
FY23
CTRE β
HR $269M
FY24
CTRE β
HR $253M
FY25
CTRE β
HR $127M
CTRE
HR
FY16
CTRE β
HR 2.5%
FY17
CTRE β
HR 2.0%
FY18
CTRE β
HR β
FY19
CTRE β
HR β
FY20
CTRE β
HR β
FY21
CTRE β
HR β
FY22
CTRE β
HR β
FY23
CTRE 5.8%
HR β
FY24
CTRE 6.4%
HR β
FY25
CTRE 9.3%
HR β
CTRE
HR
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.